Workflow
YAXING CHEMICAL(600319)
icon
Search documents
亚星化学(600319) - 2022 Q4 - 年度财报
2023-04-19 16:00
2022年年度报告 公司代码:600319 公司简称:亚星化学 潍坊亚星化学股份有限公司 2022 年年度报告 ...
亚星化学(600319) - 2023 Q1 - 季度财报
2023-04-19 16:00
2023 年第一季度报告 证券代码:600319 证券简称:亚星化学 潍坊亚星化学股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 □适用 √不适用 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位:元 币种:人民币 | 项目 | 本报告期 | 本报告期比上年同期增减 | | --- | --- | --- | | | | 变动幅度(%) | | 营业收入 | 204,381,878.99 | 32.25 | | 归属于上市公司股东的净利润 | -18,674,308.94 | 不适用 | | 归属于上市公司股东的扣除非经常 | -19,077,332.45 | 不适用 | | ...
亚星化学(600319) - 潍坊亚星化学股份有限公司关于参加山东辖区上市公司2022年度投资者网上集体接待日活动的公告
2022-11-11 08:11
股票代码:600319 股票简称:亚星化学 编号:临 2022-064 潍坊亚星化学股份有限公司 关于参加山东辖区上市公司 2022 年度 投资者网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 为进一步加强与广大投资者的沟通交流工作,使投资者能更深入全面地了解 公司情况,构建和谐投资者关系,潍坊亚星化学股份有限公司(以下简称"公司") 将参加由山东证监局、山东上市公司协会联合举办并由深圳市全景网络有限公司 承办的"山东辖区上市公司 2022 年度投资者网上集体接待日"活动,现将有关 事项公告如下: 本次投资者网上集体接待日活动将通过深圳市全景网络有限公司提供的网 上平台举行,投资者可以登录全景网"投资者关系互动平台"网站(http://ir.p5w.net/) 参与公司本次投资者网上集体接待日活动。 网上互动交流时间为 2022 年 11 月 16 日(星期三)14:00-16:00。 届时,公司财务总监伦秀华先生、董事及董事会秘书李文青先生将通过网络 在线形式与投资者进行沟通交流,欢迎广大投资者积极 ...
亚星化学(600319) - 2022 Q3 - 季度财报
2022-10-27 16:00
Financial Performance - The company's operating revenue for Q3 2022 was ¥214,594,399.14, representing a year-on-year increase of 193.39%[5] - The net profit attributable to shareholders for the same period was ¥32,649,425.93, with a year-to-date net profit of ¥62,491,903.19, showing significant growth[5] - Total operating revenue for the first three quarters of 2022 reached ¥616,495,379.62, a significant increase from ¥97,408,769.32 in the same period of 2021[24] - Net profit for the third quarter of 2022 was ¥62,491,903.19, a turnaround from a net loss of ¥34,717,362.35 in the same quarter of 2021[26] - The total profit for the third quarter of 2022 was ¥65,552,656.02, compared to a loss of ¥34,662,287.56 in the same quarter of 2021[25] Earnings Per Share - The basic earnings per share for Q3 2022 was ¥0.10, while the diluted earnings per share was also ¥0.10[6] - Basic and diluted earnings per share for the third quarter of 2022 were both ¥0.19, compared to a loss of ¥0.11 per share in the previous year[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,986,073,089.46, an increase of 11.46% compared to the end of the previous year[6] - The company's total liabilities decreased to RMB 1,394,725,814.64 from RMB 1,550,024,625.47, indicating a reduction of about 10%[22] - The company's current assets totaled RMB 348,539,325.70, compared to RMB 316,031,015.74 at the end of 2021, reflecting a growth of approximately 10.5%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,696[12] - The largest shareholder, Weifang Urban Construction Development Investment Group, holds 112,115,384 shares, representing 28.9% of the total shares[12] - The second largest shareholder, Weifang Yaxing Group, holds 23,832,797 shares, accounting for 6.15% of the total shares[12] - The company has a total of 41,653,962 shares held by four investment partnerships, representing 10.74% of the total shares[15] - The top ten shareholders collectively hold a significant portion of the company's shares, with no reported related party transactions among them[16] Cash Flow - Cash flow from operating activities for the year-to-date was ¥155,805,692.38[6] - Net cash flow from operating activities for the first three quarters of 2022 was ¥155,805,692.38, compared to a negative cash flow of ¥60,410,662.82 in 2021[28] - Cash inflow from investment activities in the first three quarters of 2022 was ¥271,665,499.44, down from ¥1,348,363,685.69 in the same period of 2021[29] - Cash flow from financing activities in the first three quarters of 2022 resulted in a net outflow of ¥177,139,173.61, compared to a net inflow of ¥215,409,674.85 in the previous year[29] - The ending cash and cash equivalents balance for the third quarter of 2022 was ¥106,868,756.40, down from ¥144,783,004.56 at the end of the same period in 2021[29] Inventory and Accounts Receivable - The company reported a significant increase in accounts receivable by 199.81% due to higher sales revenue[9] - The inventory increased by 61.07% compared to the beginning of the period, indicating a rise in stock levels[9] - The company's inventory increased to RMB 105,475,111.85 from RMB 65,482,098.82, representing a growth of approximately 61% year-over-year[21] Capital Raising and Investments - The company issued 72,115,384 new ordinary shares in a private placement, increasing the controlling shareholder's stake to 28.92%[15] - The company has received approval for a non-public offering of A-shares, with the issuance report published on July 28, 2022[15] - The company raised approximately RMB 297 million through a non-public offering of 72,115,384 shares at a price of RMB 4.16 per share, with net proceeds after expenses amounting to RMB 297,020,063.48[18] - The company is in the process of advancing the investment in the magnesium chemical project, pending shareholder approval and regulatory procedures[17] Asset Disposal - The company recognized a land disposal gain of ¥31,327,529.01 during the reporting period[8] - The company recognized asset disposal gains of RMB 31.33 million from the completion of land storage procedures for the old factory area[19]
亚星化学(600319) - 2022 Q2 - 季度财报
2022-08-09 16:00
Financial Performance - The company's operating revenue for the first half of 2022 reached RMB 401,900,980.48, a significant increase of 1,556.26% compared to RMB 24,265,545.78 in the same period last year[18]. - The net profit attributable to shareholders was RMB 29,842,477.26, recovering from a loss of RMB 12,148,903.23 in the previous year[18]. - Basic earnings per share for the first half of 2022 were RMB 0.09, compared to a loss of RMB -0.04 in the same period last year[19]. - The company reported a net loss of CNY 957,363,553.82, compared to a loss of CNY 987,206,031.08 in the previous period, showing an improvement of approximately 3.0%[82]. - The total comprehensive income for the period was CNY -12,859,259.36, indicating a loss compared to the previous period[98]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at RMB -71,160,152.53, slightly improved from RMB -77,810,269.47 in the same period last year[18]. - The net cash flow from investment activities was ¥116,156,486.14, a substantial improvement from -¥60,030,966.91 in the previous year[35]. - The total cash and cash equivalents at the end of the period stood at 11,403,705.50 RMB, down from 38,998,786.18 RMB at the end of the first half of 2021[92]. - The company's cash and cash equivalents at the end of the period totaled CNY 26,109,693.45, a decrease from CNY 86,980,239.66 at the beginning of the period[196]. Assets and Liabilities - The company's total assets increased by 4.63% to RMB 1,864,352,557.08 compared to RMB 1,781,859,933.62 at the end of the previous year[18]. - Total liabilities increased to CNY 1,602,674,771.67, up from CNY 1,550,024,625.47, reflecting a growth of approximately 3.3%[82]. - Current liabilities totaled CNY 1,375,489,538.38, a decrease of about 4.6% from CNY 1,442,551,810.22[82]. - Non-current liabilities rose significantly to CNY 227,185,233.29, compared to CNY 107,472,815.25, marking an increase of approximately 111.1%[82]. Production and Operations - The company successfully launched a 120,000-ton/year caustic soda facility in April 2022, achieving full production capacity[20]. - The construction of the 150,000 tons/year hydrogen peroxide project is underway, with 40% of the civil engineering completed by the end of June 2022[29]. - The first set of 50,000 tons/year CPE and 120,000 tons/year ion membrane caustic soda projects have been completed and are operational[29]. - The company is currently in the process of recovering production capacity following the relocation of its manufacturing facilities, which may impact future performance[7]. Environmental Compliance - The wastewater discharge concentration for ammonia nitrogen was 0.338 mg/L, with a total discharge of 0.0487 tons from January to June, meeting standards[49]. - The chemical oxygen demand (COD) concentration was 18.5 mg/L, with a total discharge of 2.95 tons from January to June, also meeting standards[49]. - The company has established a self-monitoring plan for environmental compliance, including wastewater, waste gas, soil, groundwater, and noise monitoring, with online monitoring systems operating normally[54]. - There were no administrative penalties for environmental issues during the reporting period[55]. Financing and Shareholder Information - The company raised a total of RMB 299,999,997.44 through a non-public offering of 72,115,384 shares at a price of RMB 4.16 per share[20]. - The company has a total of 63,832,797 shares controlled by the controlling shareholder, accounting for 20.22% of the total share capital[75]. - The company has fully repaid all loans applied for from Weifang City Investment Group as of the report release date[62]. Regulatory and Compliance Issues - The company received a regulatory warning from the Shanghai Stock Exchange due to inaccuracies in financial disclosures, emphasizing the need for improved compliance and internal management[59]. - The financial report for the first half of 2022 was approved by the board of directors on August 9, 2022[104]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring that the financial statements reflect a true and complete picture of its financial status and performance[109][110]. Research and Development - Research and development expenses for the first half of 2022 amounted to ¥3,297,434.85, compared to ¥2,168,088.11 in the first half of 2021, indicating a focus on innovation and development[86]. Accounting Policies - The company has not made any changes to significant accounting policies or estimates during the reporting period[194]. - The company uses the expected credit loss model to assess the impairment of financial instruments, considering historical repayment data and macroeconomic indicators[190].
亚星化学(600319) - 2021 Q4 - 年度财报
2022-05-08 16:00
Financial Performance - In 2021, the company's operating revenue reached approximately CNY 192.70 million, a significant increase of 290.93% compared to CNY 49.29 million in 2020[21]. - The net profit attributable to shareholders of the listed company was approximately CNY 193.03 million, recovering from a loss of CNY 25.67 million in 2020[21]. - The company's total assets at the end of 2021 were approximately CNY 1.78 billion, a slight decrease of 1.51% from CNY 1.81 billion in 2020[22]. - The net assets attributable to shareholders of the listed company increased to approximately CNY 231.84 million, a substantial increase of 497.05% from CNY 38.83 million in 2020[22]. - The basic earnings per share for 2021 was CNY 0.61, compared to a loss of CNY 0.08 per share in 2020[23]. - The weighted average return on net assets was 142.62% in 2021, a significant recovery from -49.62% in 2020[23]. - The company achieved operating revenue of 192.7 million RMB in 2021, an increase of 143.41 million RMB year-on-year, indicating a recovery growth trend[33]. - The net profit attributable to shareholders of the listed company for 2021 was 193 million RMB, after deducting operational losses[33]. - The company reported a significant increase in non-operating income, including government subsidies related to the relocation[28]. - The company reported a net profit attributable to shareholders significantly boosted by government compensation related to the demolition of old facilities[44]. Production and Operations - The company has resumed production and sales of CPE (Chlorinated Polyethylene) in 2021 after a halt in production since late 2019[23]. - The first phase of the 50,000 tons/year CPE project was completed and put into operation in June 2021, leading to a substantial increase in sales volume in the third and fourth quarters[26]. - The company completed the construction and operation of a 50,000 tons/year CPE facility and a 120,000 tons/year ion membrane caustic soda facility, which is ready for production[39]. - The production of CPE reached 23,998 tons, with sales volume at 22,190.60 tons, including 2,317.25 tons from trial production[48]. - The company has resumed production with a focus on high-demand product lines, ensuring continuous supply to key customers, while adjusting its sales model to increase the proportion of distribution sales temporarily[68]. Research and Development - The company’s R&D expenses rose by 128.20% to CNY 5.15 million, reflecting a focus on innovation[43]. - The total R&D investment for the period was 5,150,159.06, representing 2.67% of operating revenue[55]. - The company has 55 R&D personnel, making up 6.52% of the total workforce[56]. - The company is committed to R&D for new product categories and applications in CPE, aiming for strategic transformation and upgrades[89]. - The company has initiated feasibility studies and early development for new products, including magnesium series chemicals and conductive polymer materials, leveraging local resources[70]. Financial Management - The company’s financial expenses increased by approximately CNY 20 million due to new related party borrowings and changes in accounting for financial costs during the relocation period[42]. - The net cash flow from financing activities was CNY 187.87 million, a decrease of 76.49% compared to the previous period[44]. - The company received a total of 1.051 billion RMB in relocation compensation funds, which significantly increased the annual net profit and year-end net asset value[33]. - The company proposed a non-public offering of A-shares to raise up to 300 million RMB for working capital, with the plan already accepted by the China Securities Regulatory Commission[34]. - The company received a bank loan of 23.5 million while repaying 1.25 million in due loans during the reporting period[60]. Governance and Compliance - The company held 4 shareholder meetings, 11 board meetings, and 5 supervisory board meetings during the reporting period, ensuring compliance with regulations and equal rights for all shareholders[93]. - The company maintained independent operations, with no interference from the controlling shareholder or actual controller in business decisions[94]. - The company’s governance structure complies with relevant laws and regulations, ensuring operational independence from its controlling shareholder[97]. - The company received a disciplinary notice from the Shanghai Stock Exchange for incomplete information disclosure regarding a major asset restructuring, leading to significant stock price fluctuations[116]. - The company plans to strictly adhere to legal and regulatory requirements for information disclosure in the future[117]. Environmental and Social Responsibility - The company has established a self-monitoring plan for environmental compliance, including regular monitoring of wastewater, air emissions, soil, groundwater, and noise[143]. - The company has made significant investments in environmental protection measures, including the installation of dust suppression systems at construction sites[137]. - The company emphasizes employee rights and welfare, providing a comprehensive compensation and benefits system to support staff development[147]. - The company has developed emergency response plans for environmental incidents related to production shutdowns and relocations[142]. - The company faced an administrative penalty of 550,000 yuan due to exceeding particulate matter emission standards, which has since been rectified[145]. Future Outlook - The company provided a performance guidance for 2022, expecting revenue to grow by 20% to reach approximately 1.8 billion[103]. - New product launches are anticipated to contribute an additional 300 million in revenue in 2022[103]. - The company plans to implement a second phase project for an additional 50,000 tons/year CPE facility and a 150,000 tons/year hydrogen peroxide project, with construction already underway[74]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 200 million allocated for potential deals[103]. - The company aims to complete the construction of a 150,000 tons/year hydrogen peroxide project and a second 50,000 tons/year CPE facility to restore profitability in 2022[88].
亚星化学(600319) - 2022 Q1 - 季度财报
2022-04-29 16:00
2022 年第一季度报告 证券代码:600319 证券简称:*ST 亚星 潍坊亚星化学股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务报表 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位:元 币种:人民币 | 项目 | 本报告期 | 本报告期比上年同期增减 | | --- | --- | --- | | | | 变动幅度(%) | | 营业收入 | 154,542,852.91 | 191,312.33 | | 归属于上市公司股东的净利润 | -3,780,195.06 | 不适用 | | 归属于上市公司股东的扣除非经常 | -4,326,071.64 | 不适用 | ...
亚星化学(600319) - 2021 Q4 - 年度财报
2022-03-04 16:00
Financial Performance - The company's operating revenue for 2021 was approximately ¥192.70 million, representing a 290.93% increase compared to ¥49.29 million in 2020[21]. - The net profit attributable to shareholders for 2021 was approximately ¥193.03 million, a significant recovery from a loss of ¥25.67 million in 2020[21]. - The net profit after deducting non-recurring gains and losses was approximately -¥72.34 million, worsening from -¥37.91 million in 2020[21]. - The total assets at the end of 2021 were approximately ¥1.87 billion, a decrease of 3.94% from ¥1.94 billion at the end of 2020[21]. - The net assets attributable to shareholders increased by 497.05% to approximately ¥231.84 million from ¥38.83 million in 2020[21]. - The cash flow from operating activities for 2021 was approximately -¥83.54 million, compared to -¥35.54 million in 2020[21]. - The basic earnings per share for 2021 was 0.61 RMB, a recovery from a loss of 0.08 RMB in 2020[22]. - The company reported a net loss of CNY 987,206,031.08 in 2021, an improvement from a net loss of CNY 1,180,231,950.44 in 2020, indicating a reduction in losses of about 16.4%[182]. - The total comprehensive income for 2021 was ¥214,836,327.22, compared to a loss of ¥23,327,182.91 in 2020[188]. Operational Developments - The company completed the construction and commissioning of a 50,000 tons/year CPE production facility in 2021, marking the resumption of production after relocation[30]. - The company plans to implement a second 50,000 tons/year CPE production facility and a 150,000 tons/year hydrogen peroxide project, with necessary approvals already obtained[30]. - The production of CPE started in June 2021, with a total production volume of 23,998 tons and sales volume of 22,190.60 tons, including 2,317.25 tons from trial production[47]. - The company has restored an annual production capacity of 50,000 tons for chlorinated polyethylene (CPE) and is prioritizing high-demand product markets while ensuring continuous supply to key customers[61]. - The company’s CPE production facility has been completed and is operational, enhancing its competitive position in the high-end product market[60]. Strategic Initiatives - The company is focusing on sustainable development and resource-saving practices as part of its new circular economy strategy[36]. - The company is considering strategic acquisitions to bolster its product portfolio, with a budget of 100 million allocated for potential deals[100]. - The company is investing 50 million in R&D for new technologies aimed at enhancing product efficiency[100]. - The company has initiated feasibility studies and preliminary development for new product categories, including magnesium series chemicals and conductive polymer materials[64]. - The company plans to complete the construction of a 150,000 tons/year hydrogen peroxide project and a second 50,000 tons/year CPE facility to restore profitability[81]. Governance and Compliance - The company has established a risk management framework to address potential delays in project completion and funding challenges[83]. - The independent directors actively fulfill their duties and provide objective opinions on board matters, ensuring the protection of all shareholders' rights[88]. - The company has established a performance evaluation and incentive mechanism for senior management, ensuring accountability[90]. - The company is committed to improving its operational compliance and enhancing investor communication following the disciplinary actions[109]. - The company has successfully completed the restructuring of its board and supervisory board, enhancing governance[88]. Shareholder and Capital Management - The company plans to issue A-shares to its controlling shareholder, raising up to 300 million RMB to supplement working capital[32]. - The company proposed a non-public stock issuance to raise funds, with a feasibility analysis report included[94]. - The total remuneration for directors and senior management during the reporting period amounted to 3.88 million yuan[96]. - The company has outlined a three-year dividend return plan from 2021 to 2023[94]. - The company’s major shareholder, Weifang City Investment Group, now holds 21.20% of the voting rights following a voting rights delegation agreement[86]. Environmental and Social Responsibility - The company has completed environmental impact assessments for its projects, including a 50,000 tons/year CPE facility and a 120,000 tons/year ion-exchange membrane caustic soda project[128]. - The company faced an administrative penalty of 550,000 yuan due to exceeding particulate matter emission standards, which was rectified promptly[134]. - The company has established a self-monitoring plan for environmental protection, including regular monitoring of wastewater, air emissions, soil, groundwater, and noise[132]. - The company has made significant investments in employee welfare, including regular health check-ups and a comprehensive compensation system[136]. - Overall, the company remains committed to sustainable practices, aiming for a 20% reduction in carbon emissions by 2025[100].
亚星化学(600319) - 潍坊亚星化学股份有限公司关于参加山东辖区上市公司2021年度投资者网上集体接待日活动的公告
2021-11-12 07:44
股票简称:*ST亚星 股票代码:600319 编号:临2021-073 潍坊亚星化学股份有限公司 关于参加山东辖区上市公司 2021 年度投资者 网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责 任。 为进一步加强与投资者的互助交流工作,构建和谐投资者关系,潍坊亚星化 学股份有限公司(以下简称"公司")将参加由山东证监局、山东上市公司协 会联合举办并由深圳市全景网络有限公司承办的"山东辖区上市公司2021年度 投资者网上集体接待日"活动,现将有关事项公告如下: 本次投资者网上集体接待日活动将通过深圳市全景网络有限公司提供的网 上平台举行,投资者可以登录"全景·路演天下"网站(http://rs.p5w.net/) 参与公司本次投资者网上集体接待日活动。网上互动交流时间为2021年11月16 日(星期二)14:00-16:00。 届时,公司财务总监伦秀华先生、董事及董事会秘书李文青先生、证券事 务代表苏鑫先生将通过网络在线形式与投资者进行沟通交流,欢迎广大投资者 积极参与。 特此公告。 潍坊亚星化学股份 ...
亚星化学(600319) - 2021 Q3 - 季度财报
2021-10-29 16:00
Financial Performance - The company's operating revenue for Q3 2021 was ¥73,143,223.54, representing an increase of 1,685.42% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥22,568,459.12, with a year-to-date net profit of -¥34,717,362.35, indicating a significant loss[5]. - The basic and diluted earnings per share were both -¥0.07, reflecting a decrease from -¥0.11 in the previous year[6]. - Total operating revenue for the first three quarters of 2021 reached ¥97,408,769.32, a significant increase from ¥42,842,047.28 in the same period of 2020, representing a growth of approximately 127.5%[25]. - The net loss for the first three quarters of 2021 was ¥34,717,362.35, worsening from a net loss of ¥19,979,155.37 in the same period of 2020[25]. - The total comprehensive income attributable to the parent company was -34,717,362.35 CNY, compared to -19,979,155.37 CNY in the same period last year, indicating a decline[26]. Assets and Liabilities - Total assets increased by 24.15% to ¥2,411,161,815.04 compared to the end of the previous year[6]. - The company's total assets as of September 30, 2021, amounted to ¥2,411,161,815.04, up from ¥1,942,131,835.39 at the end of 2020, reflecting an increase of approximately 24.2%[22]. - Current assets totaled ¥383,771,130.99 as of September 30, 2021, compared to ¥113,604,541.40 at the end of 2020, marking a substantial increase of about 237.5%[20]. - The total liabilities as of September 30, 2021, were ¥2,407,048,788.60, compared to ¥1,903,301,446.60 at the end of 2020, representing an increase of approximately 26.4%[22]. - Long-term borrowings increased to ¥27,250,000.00 in 2021 from ¥5,000,000.00 in 2020, reflecting a rise of 445%[22]. Cash Flow - Cash flow from operating activities was -¥60,410,662.82 year-to-date, indicating negative cash flow[6]. - The net cash flow from operating activities was -60,410,662.82 CNY, an improvement from -70,270,474.18 CNY year-over-year[28]. - Cash received from sales of goods and services increased to 91,446,684.58 CNY, up from 67,538,467.27 CNY in the previous year, reflecting a growth of approximately 35.4%[27]. - The net cash flow from investing activities was -19,041,620.49 CNY, a decrease from 12,047,706.42 CNY in the same period last year[28]. - Cash inflow from financing activities was 1,090,950,000.00 CNY, significantly higher than 351,542,500.00 CNY in the previous year[28]. - The company received 784,500,000.00 CNY in borrowings, up from 351,542,500.00 CNY in the previous year, indicating increased leverage[28]. Research and Development - The company reported a 201.22% increase in R&D expenses, attributed to higher personnel costs[11]. - The company reported a significant increase in research and development expenses, which rose to ¥3,635,851.48 in the first three quarters of 2021 from ¥1,207,039.02 in 2020, an increase of about 201.5%[25]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,202[13]. - The largest shareholder, Weifang Urban Construction Development Investment Group, holds 40,000,000 shares, accounting for 12.6% of total shares[14]. - The second largest shareholder, Weifang Yaxing Group, holds 26,932,729 shares, representing 8.53% of total shares[14]. - The total shares held by the four shareholders associated with Weifang Yuyue Enterprise Management Co., Ltd. amount to 41,653,962 shares, or 13.2% of total shares, making them the second largest shareholder[16]. - The company has a total of 30,077,029 shares controlled by the partners of eleven shareholders, representing 9.52% of total shares, making them the third largest shareholder[16]. - The company has several shareholders with pledged shares, including Shenzhen Zhong'an Huiyin No. 1 Special Investment Enterprise, which has 12,737,632 shares pledged[13]. - The company is actively managing its shareholder structure, with no reported related party transactions among other shareholders[16]. Production and Expansion - The company plans to continue expanding its CPE production capacity and exploring new market opportunities[11]. - The company has established a new plant in Changyi City, covering approximately 1,092 acres, with ongoing construction of a 50,000 tons/year CPE facility and a 120,000 tons/year ion membrane caustic soda facility[17]. - The company is in the process of relocating equipment from the old plant, which has been fully shut down since October 31, 2019[17]. - The company’s gross profit margin improved due to the commencement of CPE production in June 2021, leading to increased sales revenue[11]. Accounting and Compliance - The company is adhering to accounting standards for the accurate processing of fixed asset revaluation as it relocates and dismantles old facilities[18].